Botikov AG
Количество цитирований статей в журналах по данным
Web of Science: 443,
Scopus: 513
IstinaResearcherID (IRID): 325043686
Деятельность
-
Статьи в журналах
-
-
2021
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
-
Gushchin Vladimir A.,
Dolzhikova Inna V.,
Shchetinin Alexey M.,
Odintsova Alina S.,
Siniavin Andrei E.,
Nikiforova Maria A.,
Pochtovyi Andrei A.,
Shidlovskaya Elena V.,
Kuznetsova Nadezhda A.,
Burgasova Olga A.,
Kolobukhina Liudmila V.,
Iliukhina Anna A.,
Kovyrshina Anna V.,
Botikov Andrey G.,
Kuzina Aleksandra V.,
Grousova Daria M.,
Tukhvatulin Amir I.,
Shcheblyakov Dmitry V.,
Zubkova Olga V.,
Karpova Oksana V.,
Voronina Olga L.,
Ryzhova Natalia N.,
Aksenova Ekaterina I.,
Kunda Marina S.,
Lioznov Dmitry A.,
Danilenko Daria M.,
Komissarov Andrey B.,
Tkachuck Artem P.,
Logunov Denis Y.,
Gintsburg Alexander L.
-
в журнале VACCINES, том 9, № 7, с. 779-779
DOI
-
-
2021
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
-
Logunov Denis Y.,
Dolzhikova Inna V.,
Shcheblyakov Dmitry V.,
Tukhvatulin Amir I.,
Zubkova Olga V.,
Dzharullaeva Alina S.,
Kovyrshina Anna V.,
Lubenets Nadezhda L.,
Grousova Daria M.,
Erokhova Alina S.,
Botikov Andrei G.,
Izhaeva Fatima M.,
Popova Olga,
Ozharovskaya Tatiana A.,
Esmagambetov Ilias B.,
Favorskaya Irina A.,
Zrelkin Denis I.,
Voronina Daria V.,
Shcherbinin Dmitry N.,
Semikhin Alexander S.,
Simakova Yana V.,
Tokarskaya Elizaveta A.,
Egorova Daria A.,
Shmarov Maksim M.,
Nikitenko Natalia A.,
Gushchin Vladimir A.,
Smolyarchuk Elena A.,
Zyryanov Sergey K.,
Borisevich Sergei V.,
Naroditsky Boris S.,
Gintsburg Alexander L.
-
в журнале The Lancet, издательство The Lancet Publishing Group (United Kingdom)
DOI
-
-
2020
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
-
Logunov DY,
Dolzhikova IV,
Zubkova OV,
Tukhvatullin AI,
Shcheblyakov DV,
Dzharullaeva AS,
Grousova DM,
Erokhova AS,
Kovyrshina AV,
Botikov AG,
Izhaeva FM,
Popova O.,
Ozharovskaya TA,
Esmagambetov IB,
Favorskaya IA,
Zrelkin DI,
Voronina DV,
Shcherbinin DN,
Semikhin AS,
Simakova YV,
Tokarskaya EA,
Lubenets NL,
Egorova DA,
Shmarov MM,
Nikitenko NA,
Morozova LF,
Smolyarchuk EA,
Kryukov EV,
Babira VF,
Borisevich SV,
Naroditsky BS,
Gintsburg AL
-
в журнале The Lancet, издательство The Lancet Publishing Group (United Kingdom), том 396, № 10255, с. 887-897
DOI